Dreman Value Management L L C maintained its position in CVS Health Corp (NYSE:CVS) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,849 shares of the pharmacy operator’s stock at the end of the second quarter. Dreman Value Management L L C’s holdings in CVS Health were worth $1,087,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of CVS. FMR LLC lifted its holdings in CVS Health by 22.0% in the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after purchasing an additional 5,446,930 shares in the last quarter. Boston Partners lifted its holdings in CVS Health by 69.1% in the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock worth $519,711,000 after purchasing an additional 2,638,888 shares in the last quarter. Parametric Portfolio Associates LLC lifted its holdings in CVS Health by 71.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock worth $317,805,000 after purchasing an additional 1,647,168 shares in the last quarter. Prudential Financial Inc. lifted its holdings in CVS Health by 61.8% in the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock worth $237,078,000 after purchasing an additional 1,125,400 shares in the last quarter. Finally, Nordea Investment Management AB lifted its holdings in CVS Health by 8.4% in the 2nd quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock worth $1,138,905,000 after purchasing an additional 1,100,373 shares in the last quarter. 82.24% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts recently commented on the company. Loop Capital lowered their price target on CVS Health from $83.00 to $73.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Needham & Company LLC boosted their price target on CVS Health from $79.00 to $85.00 and gave the stock a “buy” rating in a report on Monday, December 4th. Jefferies Group lowered their price target on CVS Health from $86.00 to $76.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Deutsche Bank assumed coverage on CVS Health in a report on Monday, December 4th. They issued a “buy” rating and a $90.00 price target on the stock. Finally, Raymond James Financial reissued a “buy” rating on shares of CVS Health in a report on Monday, December 4th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $86.35.

CVS Health Corp (NYSE:CVS) traded down $1.19 during trading hours on Wednesday, reaching $71.66. The company’s stock had a trading volume of 2,241,887 shares, compared to its average volume of 6,955,034. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.72. The company has a market cap of $74,029.46, a P/E ratio of 12.80, a price-to-earnings-growth ratio of 1.37 and a beta of 0.89.

CVS Health (NYSE:CVS) last released its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The firm had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS. equities research analysts expect that CVS Health Corp will post 5.9 EPS for the current fiscal year.

In other news, COO Jonathan C. Roberts sold 85,743 shares of the business’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the transaction, the chief operating officer now owns 119,555 shares of the company’s stock, valued at approximately $9,939,802.70. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the business’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $81.17, for a total value of $1,667,799.99. Following the transaction, the executive vice president now directly owns 43,178 shares in the company, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. In the last three months, insiders have sold 145,630 shares of company stock worth $12,017,632. Corporate insiders own 0.61% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally stolen and republished in violation of United States & international copyright and trademark law. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/13/cvs-health-corp-cvs-holdings-maintained-by-dreman-value-management-l-l-c.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related stocks with our FREE daily email newsletter.